Medical News

RSS

Galderma S.A. offers $3.75 million to NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that it has received $3.75 million in milestone payments from partner Galderma S.A.

11 Jan 2010

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

11 Jan 2010

Lives of 400 Swedes can be saved annually if side effects of pharmaceuticals prevented

A scientific study indicates that the lives of 400 Swedes could be saved annually if measures were taken to prevent side effects of pharmaceuticals. Now these researchers in Sweden, at the Nordic School of Public Health (NHV) and elsewhere, have reviewed randomly selected deaths in three Swedish counties and found that 14 percent of these deaths could have been avoided if a drug had been replaced or if the dosage had been lowered.

11 Jan 2010

First Edition: January 11, 2010

Today's headlines highlight Democrats' ongoing efforts to blend the House- and Senate-passed versions of health reform and Republican's continuing efforts to criticize the legislation.

11 Jan 2010

CHI selects Allscripts' EHR solution to enhance patient care

Allscripts announced today that Catholic Health Initiatives (CHI) has selected the Allscripts Electronic Health Record (EHR) solution for its 1050 employed physicians to enhance the quality of patient care, improve communications, and deliver more cost-effective care.

11 Jan 2010

Allscripts introduces Allscripts Stimulus Program for physicians

Allscripts today introduced the Allscripts Stimulus Program, making it safe and easy for physicians to purchase and rapidly deploy Electronic Health Records that will qualify for significant federal incentives.

11 Jan 2010

Patient News Publishing and Eco-Dentistry Association to offer premium dental newsletters

Patient News Publishing, a leading dental marketing company, is proud to announce they have teamed with the Eco-Dentistry Association to bring new articles to Patient News Publishing's dental advertising newsletter clients.

11 Jan 2010

Allscripts Care Management solution selected for Legacy Health's hospitals

Allscripts announced today that Legacy Health has selected the Allscripts Care Management solution for its six hospitals and two post-acute care facilities, helping to manage and coordinate care for the 90,000 patients it serves each year.

11 Jan 2010

A.P. Pharma regains compliance for continued listing on Nasdaq Capital Market

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on January 7, 2010, it received notice from the Nasdaq Stock Market (Nasdaq) confirming that the Company has regained compliance with the $1.00 minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Listing Rule 5450(a)(1).

11 Jan 2010

Cardiac Science and Gust Bardy launch innovation center to develop cost-effective medical products and services

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has joined with Gust Bardy, MD to create an innovation center focused on the development and commercialization of simple, cost-effective medical products and services that positively impact public health.

11 Jan 2010

Inovio Biomedical expands existing license agreement with the University of Pennsylvania

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that it has expanded its existing license agreement with the University of Pennsylvania, adding exclusive worldwide licenses for technology and intellectual property for novel DNA vaccines against pandemic influenza, Chikungunya, and foot-and-mouth disease.

11 Jan 2010

RMMC selects Allscripts' EHR and Practice Management solutions

Allscripts announced today that Renaissance Medical Management Company (RMMC) has selected the company's Electronic Health Record (EHR) and Practice Management solution to automate and connect clinical and administrative processes for a minimum of 51 family practice and internal medicine physicians.

11 Jan 2010

Illumina launches HumanOmniExpress BeadChip for GWAS

Illumina, Inc. today announced the HumanOmniExpress BeadChip (OmniExpress), the newest addition to the Omni family of microarrays for genome-wide association studies (GWAS).

From Illumina, Inc. 11 Jan 2010

ImpactRx executes $1.2 million Series E round of financing

ImpactRx® announced today that the company has executed a Series E round of financing in the amount of $1.2 million, of which the first tranche of $678,040 was closed on December 23, 2009. ImpactRx is the pioneering force in measuring the impact of pharmaceutical promotion on the prescribing behavior of the nation's highest value physicians.

11 Jan 2010

A.P. Pharma receives final milestone payment of $2.5M from Paul Capital Healthcare

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced it has received the final milestone payment of $2.5 million from an affiliate of Paul Capital Healthcare.

11 Jan 2010

Tampa Bay Partnership releases new briefs on the economic and business growth in the Tampa Bay Region

SRI International Dedicates New Tampa Bay Research Facility SRI International, one of the world's leading independent research and technology development organizations, officially opened its new 40,000-square-foot research facility located at the Port of St. Petersburg.

11 Jan 2010

Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer domain

The INSTITUT CURIE and IPSOGEN (FR0010626028 - ALIPS) announce the signing of a scientific collaboration agreement in the breast cancer domain. Within the framework of this project, the current scientific knowledge on Ipsogen's MapQuant Dx Grade Genomic, HER2 and HR tests will be increased thanks to new data established from a large population of patients treated at the Institut Curie.

11 Jan 2010

New technique may help researchers to test amyloid hypothesis in AD development

Current Alzheimer's disease (AD) research indicates that accumulation of amyloid-beta (Aβ) protein plaques in the brain is central to the development of AD.

11 Jan 2010

Mirna Therapeutics receives ETF award to develop miRNA therapeutics for multiple cancers

Mirna Therapeutics announced today that the Company received a $5 million award from the State of Texas through the Texas Emerging Technology Fund (“ETF”). The ETF was created with the goal of growing new and existing businesses to accelerate the introduction of new products and services in the marketplace. This is the largest award of this type that has ever been granted.

11 Jan 2010

Gerresheimer Group sets up new medical plastic systems production facility in Brazil

The Gerresheimer Group has set up a new facility for medical plastic systems in Indaiatuba (Brazil). The plant is to commence operations early in 2010. On the basis of a long-term cooperation agreement with Novo Nordisk, components will be produced with state-of-the-art technology for insulin pen systems for diabetics.

11 Jan 2010

Medical News

Galderma S.A. offers $3.75 million to NovaBay Pharmaceuticals

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Lives of 400 Swedes can be saved annually if side effects of pharmaceuticals prevented

First Edition: January 11, 2010

CHI selects Allscripts' EHR solution to enhance patient care

Allscripts introduces Allscripts Stimulus Program for physicians

Patient News Publishing and Eco-Dentistry Association to offer premium dental newsletters

Allscripts Care Management solution selected for Legacy Health's hospitals

A.P. Pharma regains compliance for continued listing on Nasdaq Capital Market

Cardiac Science and Gust Bardy launch innovation center to develop cost-effective medical products and services

Inovio Biomedical expands existing license agreement with the University of Pennsylvania

RMMC selects Allscripts' EHR and Practice Management solutions

Illumina launches HumanOmniExpress BeadChip for GWAS

ImpactRx executes $1.2 million Series E round of financing

A.P. Pharma receives final milestone payment of $2.5M from Paul Capital Healthcare

Tampa Bay Partnership releases new briefs on the economic and business growth in the Tampa Bay Region

Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer domain

New technique may help researchers to test amyloid hypothesis in AD development

Mirna Therapeutics receives ETF award to develop miRNA therapeutics for multiple cancers

Gerresheimer Group sets up new medical plastic systems production facility in Brazil

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News